Pharmaceutical Injectables Market Size Worth USD 2,096.91 Billion By 2027 | Emergen Research

The global pharmaceutical injectables market size was USD 698.97 Billion in 2022 and is expected to register a rapid revenue CAGR of 11.6% during the forecast period. The global pharmaceutical injectables market is witnessing substantial growth, fueled by various factors such as increasing demand for biologics and self-injectables, rising prevalence of chronic diseases, and notable advancements in medical treatments. A recent market analysis highlights the significant drivers and trends shaping the pharmaceutical injectables landscape.

Key Market Drivers

The escalating demand for injectable drugs, attributed to their superior absorption rates and quicker recovery times, is propelling market growth. Additionally, the surge in chronic diseases like Cardiovascular Diseases (CVDs), diabetes, and cancer is a pivotal factor. According to global health authorities, such as the World Health Organization (WHO) and the World Health Federation (WHF), cancer and CVDs collectively accounted for millions of deaths globally, underscoring the urgent need for effective treatments.

Moreover, recent regulatory approvals for innovative therapies, such as enzyme replacement therapies and bio-engineered anti-cancer drugs, are driving market expansion. For instance, fast-tracked approvals by regulatory bodies like the US Food and Drug Administration (USFDA) for treatments like velmanase alfa and tislelizumab signify a promising outlook for the market.

Get Free Sample Report and Related Graphs & Charts @https://www.emergenresearch.com/request-sample/2462

Technological Advancements

Technological progress in pharmaceutical injectables, exemplified by the acceptance of Biologics License Applications (BLA) and the launch of novel drugs like Bortezomib for Injection, is another significant driver. These advancements enhance treatment efficacy and contribute to the overall market growth by offering innovative solutions to healthcare providers and patients alike.

Market Restraints

Despite the promising growth trajectory, the emergence of alternative routes of administration presents a potential challenge. Alternative delivery methods offering improved bioavailability and reduced side-effects pose competition to traditional injectables. This shift underscores the need for continued innovation and adaptation within the market.

Segment Insights

• Volume Segmentation: Small volume parenteral drugs and vaccines dominate the market, driven by increasing demand and significant funding initiatives.

• Route of Administration: Intravenous (IV) and intramuscular injections are witnessing substantial growth, particularly in the context of chronic illnesses and vaccine administration.

• End-Use Segmentation: Hospitals and clinics remain key segments, with hospitals experiencing steady growth due to rising patient admissions, while clinics offer cost-effective alternatives for patients requiring medical care.

Request A Discount On The Report @https://www.emergenresearch.com/request-discount/2462

Future Outlook

Looking ahead, the pharmaceutical injectables market is poised for continued growth, fueled by advancements in technology, increasing healthcare expenditure, and a growing emphasis on patient outcomes. Market players are expected to focus on innovation, regulatory compliance, and strategic partnerships to capitalize on emerging opportunities and address evolving challenges.

Pharmaceutical Injectables Top Companies and Competitive Landscape

The global pharmaceutical injectables market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective pharmaceutical injectables solutions.

• BD
• Novo Nordisk A/S
• Amgen Inc.
• Baxter
• Gilead Sciences, Inc.
• GSK plc.
• Johnson & Johnson Private Limited
• Merck & Co., Inc.,
• Novartis AG
• Pfizer Inc.
• AbbVie Inc.
• Sanofi
• Hoffmann-La Roche Ltd

Pharmaceutical Injectables Latest Industry News

• On 4 October, 2023, Advent International and Warburg Pincus successfully acquired Baxter International Inc.'s BioPharma Solutions (BPS) division. This business will now operate independently as Simtra BioPharma Solutions ('Simtra'), A Contract Development And Manufacturing Organization (CDMO). Simtra will continue to provide its customers with essential pharmaceutical supply solutions, ensuring the availability of critical pharmaceutical products globally.

• On 28 September 2023, the UK government allocated a grant of USD 1,696,444 to support Bacterial Vaccines Network (BactiVac), based at the University of Birmingham. This funding is intended to expedite the advancement of bacterial vaccines as a crucial measure in combatting Antimicrobial Resistance (AMR) and proactively preventing infections. This initiative is a significant contribution to the global effort to address the increasing challenge of antimicrobial resistance.

Request Customization Of The Report @https://www.emergenresearch.com/request-for-customization/2462

Pharmaceutical Injectables Market Segment Analysis

For the purpose of this report, Emergen Research has segmented the global pharmaceutical injectables market on the basis of volume, route of administration, device type, end-use, and region:

• Volume Outlook (Revenue, USD Billion; 2019-2032)
o Large volume parenteral
o Small volume parenteral

• Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
o Intravenous
o Intramuscular
o Subcutaneous

• Device Type Outlook (Revenue, USD Billion; 2019-2032)
o Conventional injectables
o Pre-filled syringes
o Pen-injector
o Others

• End-use Outlook (Revenue, USD Billion; 2019-2032)
o Hospitals
o Home care
o Clinics
o Others

• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of Middle East & Africa

To Know more about the report click @ https://www.emergenresearch.com/industry-report/pharmaceutical-injectables-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

This release was published on openPR.